Shopping Cart
Remove All
Your shopping cart is currently empty
LYS006 is a highly efficient and selective LTA4H (leukotriene A4 hydrolase) inhibitor, which can be used for neutrophil-driven inflammatory diseases such as ulcerative colitis.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $68 | - | In Stock | |
| 5 mg | $163 | - | In Stock | |
| 10 mg | $278 | - | In Stock | |
| 25 mg | $553 | - | In Stock | |
| 50 mg | $893 | - | In Stock | |
| 100 mg | $1,420 | - | In Stock | |
| 200 mg | $1,890 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $179 | - | In Stock |
| Description | LYS006 is a highly efficient and selective LTA4H (leukotriene A4 hydrolase) inhibitor, which can be used for neutrophil-driven inflammatory diseases such as ulcerative colitis. |
| In vitro | Method: In vitro assays were conducted to evaluate the inhibitory effect of LYS006 on LTA4H enzymatic activity using Arg-AMC (arginine conjugated with 7-amino-4-methylcoumarin) as the substrate, with an incubation time of 15 minutes. Additionally, a human whole blood (hWB) assay was performed with a 30-minute treatment to assess the inhibition of LTB4 biosynthesis. Result: LYS006 effectively inhibited the hydrolysis of Arg-AMC catalyzed by LTA4H within 15 minutes, with an IC₅₀ of 2 nM. In the hWB assay, 30-minute treatment with LYS006 inhibited LTB4 biosynthesis, with an IC₅₀ of 167 nM. [1] |
| In vivo | Method: Mice were administered a single oral dose of LYS006 (0.3 mg/kg), and the inhibition of LTB4 release was evaluated in comparison to the vehicle control group. Result: LYS006 inhibited approximately 43% of LTB4 release compared to the vehicle control group. [1] |
| Synonyms | LYS 006, LTA4H-IN-1 |
| Molecular Weight | 392.77 |
| Formula | C16H14ClFN6O3 |
| Cas No. | 1799681-85-8 |
| Smiles | C([C@H](CC(O)=O)N)N1N=C(N=N1)C2=CC=C(OC3=C(F)C=C(Cl)C=N3)C=C2 |
| Relative Density. | 1.60 g/cm3 (Predicted) |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | H2O: <1 mg/mL (insoluble) DMSO: 80 mg/mL (203.68 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (8.4 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.